31 Aug 2017
Posted by Andrew Kantor
If you give immunizations, you’ll probably want to get your annual OSHA update. (Can you say “bloodborne pathogens training”?)
Take it online from the comfort of your living room, with GPhA’s webinar, “The Dreaded OSHA Update.”
The deets: 60-minutes. September 7 at 7:30 PM. A mere $20.
One in 10 Georgians was affected by a healthcare data breach in the past year.
The headline says it all: The annual conference is being held Friday, September 15 at the Columbus Convention and Trade Center. Register to “learn the latest recommendations and best practices in immunization services.”
The U.S. has just approved the first genetic treatment — specifically for childhood leukemia. Novartis’s use of CAR-T cells will cost $475,000, but it said there would be no charge for patients who didn’t show a response within a month.
CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer too often can evade. Researchers filter those cells from a patient’s blood, reprogram them to harbor a “chimeric antigen receptor” or CAR that zeroes in on cancer, and grow hundreds of millions of copies. Returned to the patient, the revved-up cells can continue multiplying to fight disease for months or years.
Missouri widens its lawsuit with “investigative demands.”
Yet another reason — besides, you know, skin cancer — not to use a tanning bed.